 |
|
|
 |
Corrections Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.
Khan AA, Sándor GBK, Dore E, et al. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw. J Rheumatol 2008;35:1391-7. Acknowledgment of funding sources should have included the Canadian Association of Oral and Maxillofacial Surgeons Foundation for Continuing Education and Research. We regret the error. Health-related quality of life: validity, reliability, and responsiveness of SF-36, EQ-15D, EQ-5D, RAQoL, and HAQ in patients with rheumatoid arthritis. Linde L, Sørensen J, Østergaard M, Hørslev-Petersen K, Hetland ML. Health-related quality of life: validity, reliability, and responsiveness of SF-36, EQ-15D, EQ-5D, RAQoL, and HAQ in patients with rheumatoid arthritis. J Rheumatol 2008;35:1528-37. The title should read Health-related quality of life: validity, reliability, and responsiveness of SF-36, 15D, EQ-5D, RAQoL, and HAQ in patients with rheumatoid arthritis. We regret the error. |
